ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01077531
Recruitment Status : Terminated (The risk-benefit ratio for patients has changed since we initiated the study, and that the study in its current form cannot be justified)
First Posted : March 1, 2010
Last Update Posted : June 8, 2017
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 19, 2013
  Actual Study Completion Date : March 19, 2013